# Filana Therapeutics (FLNA) — Overview

FLNA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/flna

## Price

Last close $0.76 on Oct 15, 2026. 52-week range $0.68 – $4.64.

## Company profile

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $0.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | $0.00 |
| Net income (quarter) | −$8.6M |
| Net income growth (year over year) | 80.55% |
| Net margin | 0.00% |
| Return on equity | -55.78% |
| EPS (trailing twelve months) | −$0.87 |
| Book value per share | $1.32 |
| P/E (trailing twelve months) | — |
| Price to book | 0.6 |
| Debt to assets | 38.78% |
| Payout ratio | -980.20% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### How do I buy stock in Filana Therapeutics (FLNA)?

FLNA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).